Treatment Modality and Second Primary Tumors of the Head and Neck

Overview

Journal ORL J Otorhinolaryngol Relat Spec

Specialty Otorhinolaryngology

Date 2021 Sep 29

PMID 34587611

Citations 7

Authors

Gal Ben Arie

Tali Shafat

Olga Belochitski

Sabri El-Saied

Ben-Zion Joshua

Affiliations

Soon will be listed here.

Abstract

Introduction: Second primary tumors (SPTs) in head and neck cancer are thought to occur from premalignant lesions that are present at the time of the primary tumor diagnosis. The association of the modality used to treat the primary lesion with SPT occurrence is not clear.

Objective: The aim of the study was to assess the incidence of SPTs in patients with head and neck malignancies, according to treatment modality.

Methods: We conducted a retrospective cohort study. All patients who were treated at Soroka Medical Center between 2000 and 2013 for a head and neck squamous cell carcinoma were assessed. Data analysis included tumor site of the primary and second primary and treatment modality of the primary tumor. In addition, demographics as well as habits were recorded as well.

Results: Of the 184 patients included in the cohort, SPT developed in 31 patients (17%) with a median time to diagnosis of 4.3 years. Smoking was reported in 74% of those with SPT and 78% of those without. The most common site for SPT was the lungs, with 13 cases, 42% of the total SPTs. Among patients who developed an SPT, for 12 of those with an index tumor in the oral cavity or oro-hypopharynx, 8 (67%) developed an SPT in the same location; for 18 of those with an index tumor in the larynx, 11 (61%) developed a SPT in the lungs and bronchi (p = 0.001). On multivariate analysis, the treatment modality used was not found to be associated with the occurrence of SPTs and the radiotherapy showed no protective or harmful effect (HR 0.64 p = 0.24).

Conclusion: Treatment modality used for head and neck cancer does not seem to be associated with the occurrence of SPTs.

Citing Articles

Adjuvant Reirradiation With Proton Therapy in Head and Neck Squamous Cell Carcinoma.

Hsieh K, Hotca A, Dickstein D, Lehrer E, Hsieh C, Gupta V Adv Radiat Oncol. 2024; 9(4):101418.

PMID: 38778826 PMC: 11110036. DOI: 10.1016/j.adro.2023.101418.

Spindle Cell Carcinoma of Buccal Mucosa: An Unusual Presentation of Squamous Cell Carcinoma.

Tehzeeb H, Hande A, Pakhale A, Chavhan A, Akolkar S Cureus. 2024; 16(3):e57007.

PMID: 38681384 PMC: 11046168. DOI: 10.7759/cureus.57007.

Incidence of second primary cancers in oral and pharyngeal cancer patients using a large medical claims database in Japan.

Matsui M, Kawamura K, Kano K, Yoshimatsu H, Doi T, Miyake T J Dent Sci. 2023; 18(3):1047-1054.

PMID: 37404617 PMC: 10316450. DOI: 10.1016/j.jds.2022.11.025.

Treatment outcomes of squamous cell carcinoma of the lip: A retrospective study.

Babu G, Ravikumar R, Rafi M, Nair L, Nazeer F, Thomas S Oncol Lett. 2022; 25(1):8.

PMID: 36478909 PMC: 9713830. DOI: 10.3892/ol.2022.13594.

Factors associated with the development of second primary tumours in head and neck cancer patients.

Salcedo-Bellido I, Requena P, Mateos R, Ortega-Rico C, Olmedo-Requena R, Lozano-Lorca M Eur J Cancer Care (Engl). 2022; 31(6):e13699.

PMID: 36117311 PMC: 9787413. DOI: 10.1111/ecc.13699.

References

Hashibe M, Ritz B, Le A, Li G, Sankaranarayanan R, Zhang Z . Radiotherapy for oral cancer as a risk factor for second primary cancers. Cancer Lett. 2005; 220(2):185-95. DOI: 10.1016/j.canlet.2004.10.023. View

Di Martino E, Sellhaus B, Hausmann R, Minkenberg R, Lohmann M, Esthofen M . Survival in second primary malignancies of patients with head and neck cancer. J Laryngol Otol. 2002; 116(10):831-8. DOI: 10.1258/00222150260293664. View

Leon X, Quer M, Diez S, Orus C, Lopez-Pousa A, Burgues J . Second neoplasm in patients with head and neck cancer. Head Neck. 1999; 21(3):204-10. DOI: 10.1002/(sici)1097-0347(199905)21:3<204::aid-hed4>3.0.co;2-7. View

Lippman S, Hong W . Second malignant tumors in head and neck squamous cell carcinoma: the overshadowing threat for patients with early-stage disease. Int J Radiat Oncol Biol Phys. 1989; 17(3):691-4. DOI: 10.1016/0360-3016(89)90126-0. View

Gluckman J, Crissman J, Donegan J . Multicentric squamous-cell carcinoma of the upper aerodigestive tract. Head Neck Surg. 1980; 3(2):90-6. DOI: 10.1002/hed.2890030203. View

Weaver A, Fleming S, Knechtges T, Smith D . Triple endoscopy: a neglected essential in head and neck cancer. Surgery. 1979; 86(3):493-6. View

Rusthoven K, Chen C, Raben D, Kavanagh B . Use of external beam radiotherapy is associated with reduced incidence of second primary head and neck cancer: a SEER database analysis. Int J Radiat Oncol Biol Phys. 2007; 71(1):192-8. DOI: 10.1016/j.ijrobp.2007.09.045. View

Patrucco M, Aramendi M . Prognostic impact of second primary tumors in head and neck cancer. Eur Arch Otorhinolaryngol. 2015; 273(7):1871-7. DOI: 10.1007/s00405-015-3699-1. View

Chu P, Chang S, Huang J, Tai S . Different patterns of second primary malignancy in patients with squamous cell carcinoma of larynx and hypopharynx. Am J Otolaryngol. 2009; 31(3):168-74. DOI: 10.1016/j.amjoto.2008.12.004. View

10.

SLAUGHTER D, SOUTHWICK H, SMEJKAL W . Field cancerization in oral stratified squamous epithelium; clinical implications of multicentric origin. Cancer. 1953; 6(5):963-8. DOI: 10.1002/1097-0142(195309)6:5<963::aid-cncr2820060515>3.0.co;2-q. View

11.

Hong W, Lippman S, Itri L, Karp D, Lee J, Byers R . Prevention of second primary tumors with isotretinoin in squamous-cell carcinoma of the head and neck. N Engl J Med. 1990; 323(12):795-801. DOI: 10.1056/NEJM199009203231205. View

12.

Hunter K, Parkinson E, Harrison P . Profiling early head and neck cancer. Nat Rev Cancer. 2005; 5(2):127-35. DOI: 10.1038/nrc1549. View

13.

Peck B, Dahlstrom K, Gan S, Caywood W, Li G, Wei Q . Low risk of second primary malignancies among never smokers with human papillomavirus-associated index oropharyngeal cancers. Head Neck. 2012; 35(6):794-9. PMC: 3459137. DOI: 10.1002/hed.23033. View

14.

Shapshay S, Hong W, Fried M, Sismanis A, Vaughan C, STRONG M . Simultaneous carcinomas of the esophagus and upper aerodigestive tract. Otolaryngol Head Neck Surg. 1980; 88(4):373-7. DOI: 10.1177/019459988008800410. View

15.

Morris L, Sikora A, Patel S, Hayes R, Ganly I . Second primary cancers after an index head and neck cancer: subsite-specific trends in the era of human papillomavirus-associated oropharyngeal cancer. J Clin Oncol. 2010; 29(6):739-46. PMC: 3056657. DOI: 10.1200/JCO.2010.31.8311. View

16.

Mao L, Hong W, Papadimitrakopoulou V . Focus on head and neck cancer. Cancer Cell. 2004; 5(4):311-6. DOI: 10.1016/s1535-6108(04)00090-x. View

17.

Hall J, Angele S . Radiation, DNA damage and cancer. Mol Med Today. 1999; 5(4):157-64. DOI: 10.1016/s1357-4310(99)01435-5. View

18.

Braakhuis B, Tabor M, Leemans C, van der Waal I, Snow G, Brakenhoff R . Second primary tumors and field cancerization in oral and oropharyngeal cancer: molecular techniques provide new insights and definitions. Head Neck. 2002; 24(2):198-206. DOI: 10.1002/hed.10042. View

19.

Rennemo E, Zatterstrom U, Evensen J, Boysen M . Reduced risk of head and neck second primary tumors after radiotherapy. Radiother Oncol. 2009; 93(3):559-62. DOI: 10.1016/j.radonc.2009.08.005. View

20.

Lin K, Patel S, Chu P, Matsuo J, Singh B, Wong R . Second primary malignancy of the aerodigestive tract in patients treated for cancer of the oral cavity and larynx. Head Neck. 2005; 27(12):1042-8. DOI: 10.1002/hed.20272. View